What Are the Recent Trends in Health Sector Employment - KFF

While health-related barriers to workforce participation cost Canada more than $100 billion in economic output in 2025, reducing those barriers by 25 per cent could recover more than $25 billion annually, according to a new report by Deloitte Canada. “I don’t think the connection between health and the economy is necessarily new,” says Michelle Theroux, national health leader at Deloitte Canada. “But $25 billion is a lot of money. . . . We do believe health belongs on the competitiveness agenda and should be treated with the same discipline and measurement rigor that the country applies to trade, capital and other types of investments related to the economy.”

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.